Alpha-defensins inhibit HIV infection of macrophages... : AIDS (original) (raw)

The possible involvement of α-defensins in CD8 T-cell-mediated anti-HIV activities has been the subject of recent investigations [1–3]. HIV host defence mechanisms are partly mediated by CD8 T-cell non-cytotoxic antiviral responses [4]. Walker et al. [5] first demonstrated that this anti-HIV activity involves a soluble factor(s) designated as CD8 cell antiviral factor (CAF) whose identity remains unknown [4]. Zhang et al. [1] proposed that α-defensins are produced by CD8 T cells and contribute to CAF-mediated anti-HIV activities. In contrast, the recent studies by Mackewicz et al. [2] and Chang et al. [3] demonstrated that the α-defensins are not produced by CD8 T cells but unexpectedly were found to be expressed by monocytes [2].

As CAF-mediated anti-HIV activity is also observed for macrophages [6,7] and monocytes express α-defensins [2], we investigated the capacity of α-defensins to suppress HIV infection of macrophages. The addition of α-defensins to peripheral blood monocyte-derived macrophage cultures markedly suppressed HIV Bal replication (Fig. 1a) [8,9]. In order to determine the mechanism(s) responsible for α-defensin-mediated HIV inhibition in macrophages, we investigated whether α-defensins regulate the expression of CC-chemokines. CC-chemokines [macrophage inflammatory protein (MIP)-1α, MIP-1β and Rantes] inhibit infection by competing with HIV M-tropic strains for the CCR5 receptor on macrophages [10,11]. Our experiments demonstrated that α-defensins dramatically enhance expression (as much as a 25-fold increase) of MIP-1α and MIP-1β messenger RNA in macrophages (Fig. 1b) [12]. This increased CC-chemokine gene expression by α-defensins was further confirmed by the demonstration of increased production (as much as a 57-fold increase) of MIP-1α and MIP-1β proteins in α-defensin-treated macrophage cultures (Fig. 1c). In addition, the antibodies to CC-chemokines completely abrogated α-defensin-mediated HIV inhibition in macrophages (Fig. 1d). Our data, therefore, indicate that the α-defensin-mediated inhibition of HIV infection of macrophages is mediated through the upregulation of CC-chemokines. This pathway is distinct from the anti-HIV activity of CAF in macrophages, because CC-chemokines are not responsible for the ability of CAF to suppress HIV infection of these cells [6,7].

Fig. 1.:

Effect of α-defensins on HIV infection and β-chemokine expression in macrophages. Monocytes were purified from peripheral blood of three healthy HIV-negative adult donors according to our previously described techniques and were maintained as monocyte-derived macrophages [8]. Monocytes (> 98% purity) were plated in 48-well culture plates at a density of 5 × 105 cells/well in Dulbecco's modified essential medium containing 10% fetal calf serum. (a) Macrophages maintained for 7 days were preincubated with or without α-defensins (25 μM, hNP-1 and hNP-2; Chemi-Con International, Inc., Temecula, CA, USA) for 24 h and were then infected with HIV Bal strain. HIV replication in infected macrophage cultures was analysed by measuring reverse transcriptase (RT) activity in culture supernatants [9] at day 8 post-infection and was expressed as a percentage of control (infected and untreated macrophage cultures), which was defined as 100%. (b) Macrophages were incubated with or without α-defensins (25 μM) for 3 h and total RNA isoisolated from the cells was subjected to real-time reverse trancriptase–polymerase chain reaction [12] for quantification of macrophage inflammatory protein (MIP)-1α and MIP-1β messenger RNA. (c) Macrophages were incubated with or without α-defensins for 24 h, the culture supernatants were collected for CC-chemokine production using enzyme-linked immunosorbent assay kits (Endogen, Inc., Cambridge, MA, USA). (d) Macrophages were incubated with or without α-defensins or goat neutralizing polyclonal antibodies (25 μg/ml each) to human CC-chemokines (MIP-1α, MIP-1β and regulated upon activation: normal T cell expressed/secreted [Rants]; R&D Systems, Minneapolis, MN, USA) and goat IgG (control antibody; 75 μg/ml) for 24 h and were then infected with HIV Bal strain. HIV reverse transcriptase activity in the culture supernatants was measured at day 8 post-infection.

The biological interaction of defensins with chemokines and chemokine receptors has been documented. Defensins functionally overlap with chemokines in microbicidal activity [13]. The treatment of dendritic cells with β-defensin-2 upregulated the expression of CC-chemokines (MIP-1α and MIP-1β) and downregulated CCR5 expression [14]. By utilizing chemokine receptors on immune cells, defensins may contribute to the regulation of host adaptive immunity against microbial invasion [15]. Taken together, our data provide evidence that α-defensins could play a role in host defence against HIV infection of macrophages. The biological interaction of α-defensins with CC-chemokines may constitute a unique mechanism of innate immunity against HIV disease.

References

1. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, et al.Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 ac activity of CD8 antiviral factor.Science 2002, 298: 995–1000.

2. Mackewicz CEYJ, Tran P, Diaz L, Mack E, Selsted ME, Levy JA. α-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors.AIDS 2003, 17:F23–F32.

Cited Here

3. Chang TL, Francois F, Mosoian A, Klotman ME. CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition.J Virol 2003, 77:6777–6784.

4. Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells.Immunol Today 1996, 17:217–224.

5. Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.Science 1986, 234:1563–1566.

6. Moriuchi H, Moriuchi M, Combadiere C, Murphy PM, Fauci AS. CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages.Proc Natl Acad Sci U S A 1996, 93:15341–15345.

7. Barker E, Bossart KN, Levy JA. Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines.Proc Natl Acad Sci U S A 1998, 95:1725–1729.

8. Hassan NF, Campbell DE, Douglas SD. Purification of human monocytes on gelatin-coated surfaces.J Immunol Methods 1986, 95:273–276.

9. Ho WZ, Lioy J, Song L, Cutilli JR, Polin RA, Douglas SD. Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1.J Virol 1992, 66: 573–579.

10. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.Science 1995, 270:1811–1815.

11. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, et al.CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.Science 1996, 272:1955–1958.

12. Guo CJ, Douglas SD, Lai JP, Pleasure DE, Li Y, Williams M, et al.Interleukin-1beta stimulates macrophage inflammatory protein-1alpha and -1beta expression in human neuronal cells (NT2-N).J Neurochem 2003, 84:997–1005.

13. Ganz T. Defensins and host defense.Science 1999, 286: 420–421.

14. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, et al.Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.Science 2002, 298: 1025–1029.

15. Yang D, Biragyn A, Kwak LW, Oppenheim JJ. Mammalian defensins in immunity: more than just microbicidal.Trends Immunol 2002, 23:291–296.